OMOP Internationally

The use of OMOP is growing rapidly around the world. By the end of 2024, data sources covering roughly 12% of the world's population had been standardised and harmonised with OMOP.

Standardised data sources
544
Countries
54
Patient records – about 12% of the world's population
974M

Status at the end of 2024

Key networks

The global OHDSI community develops the methods and tools around OMOP. In Europe, important contributors include EHDEN and DARWIN EU.

OHDSI logo

OHDSI

Global open-science network

The Observational Health Data Sciences and Informatics (or OHDSI, pronounced "Odyssey") network is a multi-stakeholder, interdisciplinary collaborative to bring out the value of health data through large-scale analytics.

OHDSI aims to generate accurate, reproducible, and well-calibrated evidence and promote better health decisions and better care.

Visit website
OHDSI Europe logo

OHDSI Europe

The European OHDSI community

OHDSI Europe is led by the coordinating center embedded in the Health Data Science Group of the Erasmus University Medical Center in Rotterdam, The Netherlands.

It builds a strong European OHDSI community that actively contributes to the further extension of the OMOP CDM and analytical tool development.

Visit website
European Health Data & Evidence Network (EHDEN) logo

European Health Data & Evidence Network (EHDEN)

Federated real-world data network, launched in 2018

EHDEN was launched in November 2018 to address the challenges of generating insights and evidence from real-world clinical data at scale – supporting patients, clinicians, payers, regulators, governments and industry. The OMOP Common Data Model is at the heart of EHDEN.

It has enabled large-scale, privacy-preserving research through a common framework, accelerating real-world evidence generation and establishing Europe as a global leader in federated health data science and infrastructure.

data partners
160+
certified SMEs
60
countries
29
Visit website
DARWIN EU® logo

DARWIN EU®

EMA's real-world evidence network

The Data Analysis and Real World Interrogation Network (DARWIN EU®) is the coordination centre established by the European Medicines Agency (EMA) and the European Medicines Regulatory Network to provide timely and reliable evidence on the use, safety and effectiveness of medicines, including vaccines, from real-world healthcare databases across the EU.

It has created a permanent federated network of real-world health data standardised to the OMOP Common Data Model, and has already delivered studies supporting regulatory decisions on drug safety, effectiveness and disease epidemiology.

data partners
30
patients
~180M
European countries
16
studies, up 47.5% year-over-year
59
of initial requests feasible, up from 60%
78%
median time from protocol approval to results
4 mo

From DARWIN EU®'s report, early 2025

Visit website

Know of an initiative we should feature?

More international examples will be added to this page. Get in touch if you would like to suggest one.

Contact us
OMOP Sweden Logo

christian@passion2improve.se

Bastuvägen 51
13836 Älta
Sweden

LinkedIn Logo